A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?Wei Li, Ping Huang, Xiufang He et al.|Cardiovascular Therapeutics|2021Cited by 16
Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki DiseaseWei Li, Ping Huang, Huimei Lin et al.|International Journal of Clinical Practice|2022Cited by 8
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trialYujian Wu, Xu Zhang, Lin Hu et al.|American Heart Journal|2024Cited by 7
Impact of Platelet Glycoprotein Ia/IIa C807T Gene Polymorphisms on Coronary Artery Aneurysms of KD PatientsWei Li, Xiaoqiong Gu, Lei Pi et al.|Cardiology Research and Practice|2021Cited by 4
Clinical analysis of 52 cases of pediatric hypertrophic cardiomyopathyXijing Huang, Lin Hu, Li Zhang et al.|Zhonghua shiyong erke linchuang zazhi|2019Cited by 0